| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 43,450 | 43,520 | 16:09 | |
| 43,440 | 43,520 | 16:09 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 43,600 | 441 | |||
| 43,565 | 577 | |||
| 43,490 | 250 | |||
| 43,470 | 1.100 | |||
| 43,465 | 128 | |||
| 43,430 | 250 | |||
| 43,425 | 449 | |||
| 43,335 | 280 | |||
| 43,295 | 156 | |||
| 43,265 | 96 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/0qf.htm [/URL] | ||||
| 106 | 43,195 | |||
| 211 | 43,190 | |||
| 203 | 43,185 | |||
| 560 | 43,180 | |||
| 203 | 43,170 | |||
| 117 | 43,110 | |||
| 1.100 | 43,055 | |||
| 900 | 42,970 | |||
| 250 | 42,965 | |||
| 250 | 42,945 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 3.900 | 0,956 | 3.727 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 15:49:28 | 43,025 | 40 |
| 15:48:35 | 42,915 | 34 |
| 15:47:40 | 42,998 | 42 |
| 15:36:28 | 42,930 | 39 |
| 15:35:39 | 42,880 | 37 |
| 15:33:56 | 42,745 | 120 |
| 15:33:45 | 42,775 | 44 |
| 15:31:28 | 43,645 | 161 |
| 15:26:45 | 43,940 | 5 |
| 15:26:45 | 43,940 | 21 |
| 15:23:04 | 44,070 | 102 |
| 15:23:04 | 44,075 | 49 |
| 15:23:04 | 43,975 | 203 |
| 15:05:03 | 43,835 | 114 |
| 15:05:03 | 43,835 | 19 |
| 15:05:00 | 43,730 | 158 |
| 11:22:19 | 44,025 | 38 |
| 11:08:28 | 44,035 | 6 |
| 11:08:28 | 44,035 | 33 |
| 11:08:28 | 43,970 | 26 |
| Tagesumsatz Xetra | -0,780 -1,78 % | 2.899 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Moderna Is Most Shorted S&P 500 Stock Now. Is It a Contrarian Buy? | 39 | Barchart.com | ||
| Di | Moderna, Inc.: Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026 | 656 | ACCESS Newswire | CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present late-breaking oral presentations on revaccination data for both mRNA-1010... ► Artikel lesen | |
| 03.04. | Top Moderna Shareholders | 22 | Investopedia | ||
| MODERNA Aktie jetzt für 0€ handeln | |||||
| 30.03. | Moderna vor entscheidender Bewährungsprobe | 762 | LYNX Broker | Moderna steht derzeit wieder stärker im Fokus technischer Beobachter. Im Chartbild zeigen sich Hinweise auf eine Stabilisierung Den vollständigen Artikel lesen ... ► Artikel lesen | |
| 27.03. | ImmunityBio vs. Moderna: Which Biotech Has More Upside Potential? | 51 | Zacks |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 05:10 | Aufgepasst! Riesiges Marktpotenzial im größten Teilbereich der Pharmabranche nutzen: mit Innovator Vidac Pharma, Platzhirsch Bayer oder Turnaround-Kandidat Evotec? | inv3st.de | Die Onkologie ist der strategisch wichtigste Wachstumsmarkt der Pharmaindustrie und gleichzeitig einer der entscheidenden Hebel zur Verbesserung der globalen Gesundheit. Aktuell erkranken weltweit rund... ► Artikel lesen | |
| Do | Vanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Calls on FDA to Withdraw Proposal from FY 2027 Legislative Agenda That Would Extend Drug Review Timelines | PR Newswire | WASHINGTON, April 9, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today highlighted a legislative proposal contained in the FDA's FY 2027... ► Artikel lesen | |
| Do | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 09.04.2026 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 09.04.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 09.04.2026ISIN NameCA29286M1059 ENGENE... ► Artikel lesen | |
| 11:57 | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Group (EN) | EQS Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| 11:51 | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Group (EN) | EQS Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen |